SG/CALL/FRESENIUS/27/0.1/20.09.24 Share Price

Warrant

DE000SQ6VGS1

Delayed Deutsche Boerse AG 11:54:47 02/07/2024 BST
0.22 EUR -4.35% Intraday chart for SG/CALL/FRESENIUS/27/0.1/20.09.24
1 month-28.12%
3 months+91.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
02/07/24 0.22 -4.35%
01/07/24 0.23 +9.52%
28/06/24 0.21 0.00%
27/06/24 0.21 0.00%
26/06/24 0.21 -8.70%

Delayed Quote Deutsche Boerse AG

Last update July 02, 2024 at 11:54 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer Société Générale Société Générale
WKN SQ6VGS
ISINDE000SQ6VGS1
Date issued 29/12/2022
Strike 27
Maturity 20/09/2024 (81 Days)
Parity 10 : 1
Emission price 0.46
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.61
Lowest since issue 0.11
Delta0.66x
Omega 8.259
Premium4.09x
Gearing12.49x
Moneyness 1.041
Difference Strike -1.095
Difference Strike %-4.06%
Spread 0.01
Spread %4.35%
Intrinsic value 0.1210

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
28.3 EUR
Average target price
37.26 EUR
Spread / Average Target
+31.65%
Consensus